<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">World J Surg Oncol</journal-id>
      <journal-title>World Journal of Surgical Oncology</journal-title>
      <issn pub-type="epub">1477-7819</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18328106</article-id>
      <article-id pub-id-type="pmc">2279132</article-id>
      <article-id pub-id-type="publisher-id">1477-7819-6-32</article-id>
      <article-id pub-id-type="doi">10.1186/1477-7819-6-32</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Merkel cell carcinoma of the upper extremity: Case report and an update</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Papamichail</surname>
            <given-names>Michail</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>mp2006gr@yahoo.co.uk</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Nikolaidis</surname>
            <given-names>Ioannis</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>ioannisnikolaidis@yahoo.gr</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Nikolaidis</surname>
            <given-names>Nicolas</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>nicnik1977@yahoo.com</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Glava</surname>
            <given-names>Chryssoula</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>chryssa_mo@hotmail.com</email>
        </contrib>
        <contrib id="A5" contrib-type="author">
          <name>
            <surname>Lentzas</surname>
            <given-names>Ioannis</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>lentzdoc@hotmail.com</email>
        </contrib>
        <contrib id="A6" contrib-type="author">
          <name>
            <surname>Marmagkiolis</surname>
            <given-names>Konstantinos</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>c.marmagiolis@gmail.com</email>
        </contrib>
        <contrib id="A7" contrib-type="author">
          <name>
            <surname>Karassavsa</surname>
            <given-names>Kriton</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>mp2006gr@yahoo.co.uk</email>
        </contrib>
        <contrib id="A8" contrib-type="author">
          <name>
            <surname>Digalakis</surname>
            <given-names>Michail</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>mp2006gr@yahoo.co.uk</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>General Hospital of Athens, ''Asklipion Voulas", Athens, Greece</aff>
      <aff id="I2"><label>2</label>Tzaneion General Hospital, Piraeus, Greece</aff>
      <aff id="I3"><label>3</label>Aberdeen Royal Infirmary Hospital, Aberdeen, UK</aff>
      <aff id="I4"><label>4</label>Montreal Heart Institute, Montreal QC, Canada</aff>
      <pub-date pub-type="collection">
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>7</day>
        <month>3</month>
        <year>2008</year>
      </pub-date>
      <volume>6</volume>
      <fpage>32</fpage>
      <lpage>32</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.wjso.com/content/6/1/32"/>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>10</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>7</day>
          <month>3</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2008 Papamichail et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <copyright-holder>Papamichail et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Papamichail
               Michail
               
               mp2006gr@yahoo.co.uk
            </dc:author><dc:title>
            Merkel cell carcinoma of the upper extremity: Case report and an update
         </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>World Journal of Surgical Oncology 6(1): 32-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1477-7819(2008)6:1&#x0003c;32&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1477-7819</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Merkel cell carcinoma is a rare but aggressive cutaneous primary small cell carcinoma. It is commonly seen in elderly affecting the head, neck, and extremities. Macroscopically may be difficult to distinguish MCC from other small cells neoplasms especially oat cell carcinoma of the lung.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>It is presented a case report concerning a 72 years old male with a MMC on the dorsal aspect of the right wrist. The patient underwent a diagnostic excisional biopsy and after the histological confirmation of the diagnosis a second excision was performed to achieve free margins. No postoperative radiation or adjuvant chemotherapy was given and within 9 years follow up no recurrence was reported.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Although most cases present as localized disease treatment should be definitive due to high rates of local or systemic recurrence. Treatment includes excision of the lesion, lymphadenectomy, postoperative radiotherapy and chemotherapy depending on the stage of the disease. Even when locoregional control is achieved close surveillance is required due to high rates of relapse.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Merkel cell carcinoma (MCC) is a rare cutaneous malignancy that was first described by Toker in 1972 [<xref ref-type="bibr" rid="B1">1</xref>]. This rare aggressive neoplasm is thought to originate from the neurocrest derivatives round shaped Merkel cells located in the basal layer of the epidermis and containing neurosecretory granules [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B5">5</xref>].</p>
      <p>Although aetiology is not fully illuminated, there are several risk factors that contribute to its pathogenesis. Those include UV light, sun-related skin malignancies (Squamous Cell Carcinoma, Basal Cell Carcinoma), psoriasis treatment with methoxsalen and arsenic exposure. Patients on immunosuppressive agents or patients with diagnosis of AIDS, chronic lymphocytic leukemia, congenital dysplasia syndrome and organ recipients carry a higher risk as well [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B11">11</xref>].</p>
      <p>Clinically, MCC appears as a painless, firm, non tender, ulcerated skin lesion commonly less than 2 cm in size at the time of presentation [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. Most cases present as localized disease (70%&#x2013;80%) followed by regional lymph node involvement (9%&#x2013;26%) and distant metastasis (1%&#x2013;4%) [<xref ref-type="bibr" rid="B8">8</xref>]. These characteristics often raise the suspicion of a skin malignancy but confirmation of diagnosis is made by excisional biopsy. The differential diagnosis of MCC from other small cells neoplasms can be difficult, even on histological examination [<xref ref-type="bibr" rid="B10">10</xref>]. For definitive diagnosis in these cases, electron microscopy is necessary [<xref ref-type="bibr" rid="B5">5</xref>].</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 72-year-old male presented in December 1998 with a painless nodular, red and firm 2 cm plaque located on the dorsal aspect of the right wrist (Figure <xref ref-type="fig" rid="F1">1</xref>) noticed 1&#x2013;2 months before. No history of previous skin lesions elsewhere was reported.</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>Macroscopic view of the lesion</p>
        </caption>
        <graphic xlink:href="1477-7819-6-32-1"/>
      </fig>
      <p>An excisional biopsy was performed. Microscopical examination of the lesion revealed the invasion of dermis and subcutaneous tissue by a small cell solid tumor with diffuse pattern of infiltration (Figure <xref ref-type="fig" rid="F2">2</xref>). The excisional margins were positive although dermal lymphatics were intact and no exceeding to the adjacent structures such us, veins, tendons or nerves was discovered. The tumor cells were small, with scanty acidophilic cytoplasm, round vescicular nuclei and multiple nucleoli (Figure <xref ref-type="fig" rid="F3">3</xref>). Mitotic figures were numerous. In immunohistochemical examination, the tumor cells showed diffuse positivity for Epithelial Membrane Antigen (EMA, Figure <xref ref-type="fig" rid="F4">4</xref>) and Neuron Specific Antigen (NSE, Figure <xref ref-type="fig" rid="F5">5</xref>). Lymphatic Common Antigen (LCA), Thyroid Transcription Factor &#x2013; 1 (TTF-1) and CD99 were negative. Based on to these histological and immunohistochemical features, diagnosis of Merkel Cell Tumor was established.</p>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p>H-E x 100       </p>
        </caption>
        <graphic xlink:href="1477-7819-6-32-2"/>
      </fig>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p>H-E x 400       </p>
        </caption>
        <graphic xlink:href="1477-7819-6-32-3"/>
      </fig>
      <fig position="float" id="F4">
        <label>Figure 4</label>
        <caption>
          <p>EMA x 400       </p>
        </caption>
        <graphic xlink:href="1477-7819-6-32-4"/>
      </fig>
      <fig position="float" id="F5">
        <label>Figure 5</label>
        <caption>
          <p>NSE x 400       </p>
        </caption>
        <graphic xlink:href="1477-7819-6-32-5"/>
      </fig>
      <p>The patient underwent an imaging evaluation with a CT scan for staging. The CT did not reveal any masses, lymphadenopathy or distant metastases. An additional excision was performed in order to achieve approximately margins 2&#x2013;3 cm wide and 1&#x2013;2 cm deep. The patient expressed the willing not to receive postoperative radiation or adjuvant chemotherapy which was justified based on the stage of the disease and the cardiovascular and pulmonary co-morbidities. We scheduled CT imaging follow up every 6 months for the first 3 years and then annually for the upcoming years. No recurrence was reported until April 2007. (Figure <xref ref-type="fig" rid="F6">6</xref>).</p>
      <fig position="float" id="F6">
        <label>Figure 6</label>
        <caption>
          <p>9 years post-op</p>
        </caption>
        <graphic xlink:href="1477-7819-6-32-6"/>
      </fig>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>MMC is an aggressive neoplasm with an overall unfavourable prognosis [<xref ref-type="bibr" rid="B12">12</xref>], therefore it requires definite treatment. It usually occurs in older patients with less than 5% cases seen before the age of 50 years and it has an annual incidence of 0.42 per 100.000. Both sexes are affected with a male predominance, although in some series higher incidence in women is reported [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. Higher likelihood is reported in whites and it affects sun exposed areas such as head and neck (50%), upper and lower limbs (35%&#x2013;40%) and less than 10% in the trunk [<xref ref-type="bibr" rid="B8">8</xref>]. It has also been reported that MMC rarely can occur on anatomic sites such as vulva, penis, pharynx and oral or nasal mucosa. [<xref ref-type="bibr" rid="B7">7</xref>].</p>
      <p>Macroscopically, MCC appears as a nodular, sometimes ulcerated skin lesion with a reddish or violaceous hue [<xref ref-type="bibr" rid="B12">12</xref>]. Microscopically, the tumor is centered in the dermis or sometimes in the subcutaneous tissue, with the overlying epidermis being usually not involved [<xref ref-type="bibr" rid="B13">13</xref>]. The tumor cells are small and round, disposed in a diffuse or, rarely, trabecular architectural pattern [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. The cytoplasm is scanty, visible as a thin eosinophilic rim. The nuclei are round and vescicular, with a typically fine granular chromatin, multiple nucleoli and numerous mitotic figures. The tumour stroma contains abundant vessels with hypertrophic endothelial cells. [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>]</p>
      <p>Immunohistochemically, the tumor cells are usually positive for low-molecular-weight cytokeratin (CK AE1), predominantly cytokeratin 20 (CK20) [<xref ref-type="bibr" rid="B17">17</xref>], neurofilaments and NSE [<xref ref-type="bibr" rid="B18">18</xref>]. Additionally to these markers, some cases of MCC have shown focal reactivity for chromogranin, synaptophysin, vasoactive intestinal peptid, pancreatic polypeptide, calcitonin, substance P, somatostatin, ACTH, other peptide hormones and CD117. [<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B24">24</xref>]</p>
      <p>Differential diagnosis has to be made between MCC and other small cell neoplasms (small cell neuroendocrine lung carcinoma, malignant lymphoma, Ewing's sarcoma/PNET category). Sometimes, tumors with an appearance identical to pulmonary small cell neuroendocrine carcinoma are found in the skin. [<xref ref-type="bibr" rid="B12">12</xref>] The consistent positivity of the MCC for CD20 and the negativity for TTF-1 are important in the differential diagnosis from small cell neuroendocrine lung carcinoma [<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B27">27</xref>]. The monotonous nature of the dermal round cell infiltrate and the diffuse pattern of infiltration are responsible for MCC's misdiagnosis as malignant lymphoma [<xref ref-type="bibr" rid="B28">28</xref>]. Differential diagnosis in this case is made using the immunohistochemical lymphatic marker LCA. Finally, differential diagnosis of MCC from PNET is base on the negativity of the neoplastic Merkel cells for CD99, positive in Ewing's sarcoma/PNET [<xref ref-type="bibr" rid="B29">29</xref>].</p>
      <p>The fact that MCC can be seen in association with in situ or invasive SCC, with duct-like structures of eccrine type, and with basal call carcinoma-like areas suggests that it originates from a potential stem cell of ectodermal derivation. [<xref ref-type="bibr" rid="B30">30</xref>-<xref ref-type="bibr" rid="B33">33</xref>]</p>
      <p>Chromosomal abnormalities localized on the short arm of chromosome 1, associated with Merkel cell tumor are common in melanoma and neuroblastoma. Chromosomal abnormalities (loss of heterozygosis in chromosome 3p21) associated with small cell lung neuroendocrine carcinoma is related to Merkel cell carcinoma as well. [<xref ref-type="bibr" rid="B8">8</xref>].</p>
      <p>Due to its rarity and the lack of cases for a randomized prospective trial no consensus of the appropriate treatment protocol for MCC is made so far [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. Therapeutic options depend on the stage of the disease at the time of presentation whereas the most important prognostic factor is the absence of nodal involvement [<xref ref-type="bibr" rid="B34">34</xref>].</p>
      <p>Surgery remains the gold standard for localized disease and is considered to be successful when margins 3 cm wide and 2 cm deep are achieved [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B34">34</xref>]. Some controversy exists showing that when the tumour size is less than 1.5&#x2013;2 cm, obtaining margins less than 2&#x2013;3 cm did not lead to higher recurrences rates. [<xref ref-type="bibr" rid="B11">11</xref>] Mohs micrographic surgery is an alternative method of wide clearance, especially on sites required excellent cosmetic results [<xref ref-type="bibr" rid="B6">6</xref>] and some studies report better rates of locoregional control [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>]. A benefit of this method is the better inspection of all major borders of the lesion. [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B36">36</xref>]</p>
      <p>Postoperative radiotherapy in node free patients either discovered clinically, with imaging techniques, with a negative sentinel node biopsy, or after routine nodal dissection still remains controversial. Due to the high rates of local relapse, routine use of 45&#x2013;60 Gy [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>] to the area of the lesion has been found to decrease local recurrence [<xref ref-type="bibr" rid="B36">36</xref>]. Other series showed no significant difference compared with surgery only [<xref ref-type="bibr" rid="B11">11</xref>] and distant metastasis and overall survival seem to be similar compared to those who did not receive radiation [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B37">37</xref>]. Postoperative radiotherapy could be beneficial in cases of large primary tumours or unattainable free surgical margins due to cosmetic or functional difficulties [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B8">8</xref>] but radiating permanent margins did not yield satisfactory results [<xref ref-type="bibr" rid="B34">34</xref>].</p>
      <p>Many authors advocate that lymph node recurrence often represents the delayed manifestation of pre-existing occult micrometastases rather than inadequate local control of primary tumour [<xref ref-type="bibr" rid="B11">11</xref>]. Based on this, sentinel node biopsy should be strongly considered. [<xref ref-type="bibr" rid="B11">11</xref>]. Involvement of the regional lymph nodes decreases dramatically the survival rates (88% to 50%) and it appears in 50%&#x2013;70% of all patients within 2 years by the time of diagnosis [<xref ref-type="bibr" rid="B38">38</xref>]. Other poor prognostic factors are tumour size &gt;2 cm, male sex, age &gt;60 years, immunosuppression and location on lower extremities [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B36">36</xref>]. Due to this high rate of spreading, prophylactic nodal clearance of free disease nodes is advocated in order to improve outcome. In some studies sentinel node status was evaluated and a sentinel node biopsy was performed in order to identify occult micrometastases, showing low relapsing rates [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. However, sentinel node biopsy is not attempted if additional therapy is not tolerated by the patient [<xref ref-type="bibr" rid="B11">11</xref>]. Based on an another study it has been recommended prophylactic lymphadenectomy only in patients with lesions present for longer than 6 weeks prior seeking medical advise or when tumour exceeds 1.5 cm in size. [<xref ref-type="bibr" rid="B10">10</xref>] Many authors advocate the routine lymph node dissection, including or not sentinel node biopsy [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B34">34</xref>] but others conclude that routine lymph node dissection improves locoregional control but has no effect on survival [<xref ref-type="bibr" rid="B39">39</xref>].</p>
      <p>When nodal infiltration is established, definite management includes complete lymphadenectomy and postoperative radiotherapy. As a result of increased rate of recurrence, even when lymph nodes have been removed, strict follow-up is required. [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B38">38</xref>].</p>
      <p>Disseminated disease whether primary or recurrent has a very poor prognosis with an average expected survival of 8 months by the time of diagnosis. Imaging techniques such as CT, MRI, PET scan and ocrteotide schintigraphy have all been used to detect regional or distant metastases. [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B11">11</xref>] Regional metastases are common, and distant metastases can also occur, particularly in liver, bone, lung, brain and skin. Rare cases of distant metastases of MCC in bone marrow, pleura, testis, small bowel and stomach have been reported [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B37">37</xref>]. Treatment in case of MCC with distal metastases consists of palliative radiotherapy and chemotherapy. Multiple agents have been used with different response rates [<xref ref-type="bibr" rid="B38">38</xref>]. Those include cyclophosphamide, doxorubicin, etoposide, cis-platinum, vincristine, methotrexate, 5-fluorouracile, carboplatinum [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B34">34</xref>]. Biologic agents such as interferon, tumour necrosis factor (TNF) and imatinib mesylate promise better results on local (TNF) or systemic control of MCC. [<xref ref-type="bibr" rid="B7">7</xref>] Radiotherapy can be used as palliative therapy of cutaneous deposits or bone and brain metastases [<xref ref-type="bibr" rid="B8">8</xref>]. Patients developing recurrence within the radiotherapy field are not candidates for further high dose radiotherapy (&gt;50 Gy) [<xref ref-type="bibr" rid="B9">9</xref>].</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>The overall 5-year survival rate for patients with Merkel cell carcinoma is 50% to 68% [<xref ref-type="bibr" rid="B38">38</xref>]. Considering the high incidence of local recurrence (27%&#x2013;60%) regional node involvement (45%&#x2013;91%) or distant metastases (18%&#x2013;52%) [<xref ref-type="bibr" rid="B8">8</xref>], treatment should be definite with close follow up. Despite the aggressiveness of MCC, early diagnosis, optimal resection with clear margins and postoperative radiotherapy achieve loco regional control of the tumor and long term survival, although radiotherapy still remains controversial [<xref ref-type="bibr" rid="B40">40</xref>]. In the cases of lymph node involvement, prognosis is less favourable considering that despite nodal dissection and adjuvant radiotherapy the majority of patients will ultimately develop distant metastases.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author(s) declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p><bold>MP</bold>: drafted the article; <bold>LN</bold>: helped in drafting the article; <bold>NN </bold>helped in drafting the draft <bold>CG </bold>carried out the immunoassays; <bold>LL</bold>: participated in the design of the study and performed the statistical analysis; <bold>MK</bold>: conceived of the study, and participated in its design and coordination and helped to draft the manuscript. <bold>KK</bold>: conceived of the study, and participated in its design and coordination and helped to draft the manuscript. <bold>MD</bold>: Supervised the preparation of the article and helped in preparation of final manuscript.</p>
      <p>All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>A written consent was obtained from the patient for publication of this case report.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toker</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Trabecular carcinoma of the skin</article-title>
          <source>Arch Dermatol</source>
          <year>1972</year>
          <volume>105</volume>
          <fpage>107</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">5009611</pub-id>
          <pub-id pub-id-type="doi">10.1001/archderm.105.1.107</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Youker</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Billingsley</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Combined Merkel cell carcinoma and atypical fibroxanthoma</article-title>
          <source>J Cutan Med Surg</source>
          <year>2005</year>
          <volume>9</volume>
          <fpage>6</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">16208439</pub-id>
          <pub-id pub-id-type="doi">10.1007/s10227-005-0024-4</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartz</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Lambert</surname>
              <given-names>WC</given-names>
            </name>
          </person-group>
          <article-title>The Merkel cell carcinoma: a 50-year retrospect</article-title>
          <source>J Surg Oncol</source>
          <year>2005</year>
          <volume>89</volume>
          <fpage>1</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">15611998</pub-id>
          <pub-id pub-id-type="doi">10.1002/jso.20165</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McAfee</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Mendenhall</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Werning</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Mendenhall</surname>
              <given-names>NP</given-names>
            </name>
            <name>
              <surname>Mendenhall</surname>
              <given-names>WM</given-names>
            </name>
          </person-group>
          <article-title>Merkel cell carcinoma: treatment and outcomes</article-title>
          <source>Cancer</source>
          <year>2005</year>
          <volume>15; 104</volume>
          <fpage>1761</fpage>
          <lpage>1764</lpage>
          <pub-id pub-id-type="pmid">16136596</pub-id>
          <pub-id pub-id-type="doi">10.1002/cncr.21355</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Payne</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Rader</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Rodgers</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>Merkel cell carcinoma in a malignant pleural effusion: case report</article-title>
          <source>Cytojournal</source>
          <year>2004</year>
          <volume>18; 1</volume>
          <fpage>5</fpage>
          <pub-id pub-id-type="pmid">15550173</pub-id>
          <pub-id pub-id-type="doi">10.1186/1742-6413-1-5</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koljonen</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Merkel cell carcinoma</article-title>
          <source>World J Surg Oncol</source>
          <year>2006</year>
          <volume>4</volume>
          <fpage>7</fpage>
          <pub-id pub-id-type="pmid">16466578</pub-id>
          <pub-id pub-id-type="doi">10.1186/1477-7819-4-7</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dinh</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Feun</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Elgart</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Savaraj</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Merkel cell carcinomas</article-title>
          <source>Hematol Oncol Clin North Am</source>
          <year>2007</year>
          <volume>21</volume>
          <fpage>527</fpage>
          <lpage>544</lpage>
          <pub-id pub-id-type="pmid">17548038</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.hoc.2007.04.008</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pectasides</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pectasides</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Economopoulos</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Merkel cell cancer of the skin</article-title>
          <source>Ann Oncol</source>
          <year>2006</year>
          <volume>24</volume>
          <fpage>1489</fpage>
          <lpage>1495</lpage>
          <pub-id pub-id-type="pmid">16565213</pub-id>
          <pub-id pub-id-type="doi">10.1093/annonc/mdl050</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Veness</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma): an overview on management</article-title>
          <source>Australas J Dermatol</source>
          <year>2006</year>
          <volume>47</volume>
          <fpage>160</fpage>
          <lpage>165</lpage>
          <pub-id pub-id-type="pmid">16866994</pub-id>
          <pub-id pub-id-type="doi">10.1111/j.1440-0960.2006.00263.x</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boyse</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Foley</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Bradley</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Scarborough</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Merkel cell carcinoma: a case report with treatment summary and updates</article-title>
          <source>Cutis</source>
          <year>2004</year>
          <volume>74</volume>
          <fpage>350</fpage>
          <lpage>356</lpage>
          <pub-id pub-id-type="pmid">15663071</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bichakjian</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Lowe</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lao</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Sandler</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Bradford</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Merkel cell carcinoma: critical review with guidelines for multidisciplinary management</article-title>
          <source>Cancer</source>
          <year>2007</year>
          <volume>110</volume>
          <fpage>1</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">17520670</pub-id>
          <pub-id pub-id-type="doi">10.1002/cncr.22765</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Rosai</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Rosai and Ackerman's Surgical Pathology</article-title>
          <source>Mosby</source>
          <year>2004</year>
          <volume>1</volume>
          <edition>9</edition>
          <fpage>177</fpage>
          <lpage>179</lpage>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bayrou</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Avril</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Charpentier</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Caillou</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Guillaume</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Prade</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Primary neuroendocrine carcinoma of the skin. Clinicopathologic study of 18 cases</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1991</year>
          <volume>24</volume>
          <fpage>198</fpage>
          <lpage>207</lpage>
          <pub-id pub-id-type="pmid">2007664</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sidhu</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Feiner</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Mullins</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Schaefler</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Schultenhover</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Merkel cell Neoplasms. Histology, electron microscopy, biology and histogenesis</article-title>
          <source>Am J Dermatopathol</source>
          <year>1980</year>
          <volume>2</volume>
          <fpage>101</fpage>
          <lpage>119</lpage>
          <pub-id pub-id-type="pmid">7246977</pub-id>
          <pub-id pub-id-type="doi">10.1097/00000372-198000220-00001</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walsh</surname>
              <given-names>NM</given-names>
            </name>
          </person-group>
          <article-title>Primary neuroendocrine (Merkel cell) carcinoma of the skin. Morphologic diversity and implications thereof</article-title>
          <source>Hum Pathol</source>
          <year>2001</year>
          <volume>32</volume>
          <fpage>680</fpage>
          <lpage>689</lpage>
          <pub-id pub-id-type="pmid">11486166</pub-id>
          <pub-id pub-id-type="doi">10.1053/hupa.2001.25904</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gaudin</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Rosai</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Florid vascular proliferation associated with neural and neuroendocrine neoplasms: a diagnostic clue and potential pitfall</article-title>
          <source>Am J Surg Pathol</source>
          <year>1995</year>
          <volume>19</volume>
          <fpage>642</fpage>
          <lpage>652</lpage>
          <pub-id pub-id-type="pmid">7538732</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scott</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Helm</surname>
              <given-names>KF</given-names>
            </name>
          </person-group>
          <article-title>Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma</article-title>
          <source>Am J Dermatopathol</source>
          <year>1999</year>
          <volume>21</volume>
          <fpage>16</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">10027519</pub-id>
          <pub-id pub-id-type="doi">10.1097/00000372-199902000-00003</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wick</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Scheithauer</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Kovacs</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Neuron-specific enolase in neuroendocrine tumours of the thymus bronchus and skin</article-title>
          <source>Am J Clin Pathol</source>
          <year>1983</year>
          <volume>79</volume>
          <fpage>703</fpage>
          <lpage>707</lpage>
          <pub-id pub-id-type="pmid">6303108</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brinkschmidt</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Stolze</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fahrenkamp</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Hundeiker</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fisher-Colbrie</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zelger</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bocker</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Schmid</surname>
              <given-names>KW</given-names>
            </name>
          </person-group>
          <article-title>Immunohistochemical demonstration of cromogranin A, chromogranin B, and secretoneurin in Merkel cell carcinoma of the skin. An immunohistochemical study on 18 cases suggesting two types of Merkel cell carcinoma</article-title>
          <source>Appl Immunohistochem</source>
          <year>1995</year>
          <volume>3</volume>
          <fpage>37</fpage>
          <lpage>44</lpage>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haneke</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Schulze</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Mahrle</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Immunohistochemical and immunoelectron microscopic demonstration of chromogranin A in formalin-fixed tissue of Merkel cell carcinoma</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1993</year>
          <volume>28</volume>
          <fpage>222</fpage>
          <lpage>226</lpage>
          <pub-id pub-id-type="pmid">8432919</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Layfield</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ulich</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Barr</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lewin</surname>
              <given-names>KL</given-names>
            </name>
          </person-group>
          <article-title>Neuroendocrine carcinoma of the skin. An immunohistochemical study of tumour markers and neuroendocrine products</article-title>
          <source>J Cutan Pathol</source>
          <year>1986</year>
          <volume>13</volume>
          <fpage>268</fpage>
          <lpage>273</lpage>
          <pub-id pub-id-type="pmid">2430002</pub-id>
          <pub-id pub-id-type="doi">10.1111/j.1600-0560.1986.tb01522.x</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sibley</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Dahl</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Primary neuroendocrine (Merkel cell?) carcinoma of the skin. II. An immunohistochemical study of 21 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>1985</year>
          <volume>9</volume>
          <fpage>109</fpage>
          <lpage>116</lpage>
          <pub-id pub-id-type="pmid">2579592</pub-id>
          <pub-id pub-id-type="doi">10.1097/00000478-198502000-00005</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Ord&#xF3;&#xF2;ez</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Lechago</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Immunohistochemical studies in neuroendocrine carcinoma of the skin</article-title>
          <source>Am J Clin Pathol</source>
          <year>1984</year>
          <volume>81</volume>
          <fpage>558</fpage>
          <lpage>562</lpage>
          <pub-id pub-id-type="pmid">6202132</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Su</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Fullen</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Lowe</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Uherova</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schnitzer</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Valder</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>CD117 (KIT receptor) expression in Merkel cell carcinoma</article-title>
          <source>Am J Dermatopathol</source>
          <year>2002</year>
          <volume>24</volume>
          <fpage>289</fpage>
          <lpage>293</lpage>
          <pub-id pub-id-type="pmid">12142606</pub-id>
          <pub-id pub-id-type="doi">10.1097/00000372-200208000-00001</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Byrd-Gloster</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Khoor</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Glass</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Messina</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Whitsett</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Livingstone</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Cagle</surname>
              <given-names>PT</given-names>
            </name>
          </person-group>
          <article-title>Differential expression of Thyroid Trascription Factor &#x2013; 1 in small cell lung carcinoma and Merkel cell tumor</article-title>
          <source>Hum Pathol</source>
          <year>2000</year>
          <volume>31</volume>
          <fpage>58</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="pmid">10665914</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0046-8177(00)80199-9</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Suster</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wenig</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Tsang</surname>
              <given-names>WY</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>AL</given-names>
            </name>
          </person-group>
          <article-title>Cytokeratin 20 immunohistochemistry distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites</article-title>
          <source>Am J Surg Pathol</source>
          <year>1997</year>
          <volume>21</volume>
          <fpage>226</fpage>
          <lpage>234</lpage>
          <pub-id pub-id-type="pmid">9042291</pub-id>
          <pub-id pub-id-type="doi">10.1097/00000478-199702000-00014</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheuk</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Kwan</surname>
              <given-names>MY</given-names>
            </name>
            <name>
              <surname>Suster</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>Immunostaining for Thyroid Trascription Factor &#x2013; 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2001</year>
          <volume>125</volume>
          <fpage>228</fpage>
          <lpage>231</lpage>
          <pub-id pub-id-type="pmid">11175640</pub-id>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wick</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Kaye</surname>
              <given-names>VN</given-names>
            </name>
            <name>
              <surname>Sibley</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Tyler</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Frizzera</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Primary neuroendocrine carcinoma and small cell malignant lymphoma of the skin. A discriminant immunohistochemical comparison</article-title>
          <source>J Cutan Pathol</source>
          <year>1986</year>
          <volume>13</volume>
          <fpage>347</fpage>
          <lpage>358</lpage>
          <pub-id pub-id-type="pmid">2946733</pub-id>
          <pub-id pub-id-type="doi">10.1111/j.1600-0560.1986.tb00469.x</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Rosai</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Rosai and Ackerman's Surgical Pathology</article-title>
          <source>Mosby</source>
          <year>2004</year>
          <volume>1</volume>
          <edition>9</edition>
          <fpage>50</fpage>
        </citation>
      </ref>
      <ref id="B30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cerroni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kerl</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Primary cutaneous neuroendocrine (Merkel cell) carcinoma in association with squamous- and basal-cell carcinoma</article-title>
          <source>Am J Dermatopathol</source>
          <year>1998</year>
          <volume>19</volume>
          <fpage>610</fpage>
          <lpage>613</lpage>
          <pub-id pub-id-type="pmid">9415620</pub-id>
          <pub-id pub-id-type="doi">10.1097/00000372-199712000-00011</pub-id>
        </citation>
      </ref>
      <ref id="B31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gomez</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>DiMaio</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Mackay</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Association between neuroendocrine (Merkel cell) carcinoma and squamous carcinoma of the skin</article-title>
          <source>Am J Surg Pathol</source>
          <year>1983</year>
          <volume>7</volume>
          <fpage>171</fpage>
          <lpage>177</lpage>
          <pub-id pub-id-type="pmid">6859392</pub-id>
        </citation>
      </ref>
      <ref id="B32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gould</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Albores-Saavedra</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dubner</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Payne</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Eccrine and squamous differentiation in Merkel cell carcinoma. An immunohistochemical study</article-title>
          <source>Am J Surg Pathol</source>
          <year>1988</year>
          <volume>12</volume>
          <fpage>768</fpage>
          <lpage>772</lpage>
          <pub-id pub-id-type="pmid">3421413</pub-id>
        </citation>
      </ref>
      <ref id="B33">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heenan</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Cole</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Spagnolo</surname>
              <given-names>DV</given-names>
            </name>
          </person-group>
          <article-title>Primary cutaneous neuroendocrine carcinoma (Merkel cell tumour). Immunohistochemical and biochemical analyses</article-title>
          <source>Virchows Arch [A]</source>
          <year>1985</year>
          <volume>406</volume>
          <fpage>339</fpage>
          <lpage>350</lpage>
        </citation>
      </ref>
      <ref id="B34">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eng</surname>
              <given-names>TY</given-names>
            </name>
            <name>
              <surname>Boersma</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Fuller</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Cavanaugh</surname>
              <given-names>SX</given-names>
            </name>
            <name>
              <surname>Valenzuela</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Herman</surname>
              <given-names>TS</given-names>
            </name>
          </person-group>
          <article-title>Treatment of merkel cell carcinoma</article-title>
          <source>Am J Clin Oncol</source>
          <year>2004</year>
          <volume>27</volume>
          <fpage>510</fpage>
          <lpage>515</lpage>
          <pub-id pub-id-type="pmid">15596922</pub-id>
          <pub-id pub-id-type="doi">10.1097/01.coc.0000135567.62750.f4</pub-id>
        </citation>
      </ref>
      <ref id="B35">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eng</surname>
              <given-names>TY</given-names>
            </name>
            <name>
              <surname>Naguib</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fuller</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>WE</given-names>
              <suffix>3rd</suffix>
            </name>
            <name>
              <surname>Herman</surname>
              <given-names>TS</given-names>
            </name>
          </person-group>
          <article-title>Treatment of recurrent Merkel cell carcinoma: an analysis of 46 cases</article-title>
          <source>Am J Clin Oncol</source>
          <year>2004</year>
          <volume>27</volume>
          <fpage>576</fpage>
          <lpage>583</lpage>
          <pub-id pub-id-type="pmid">15577435</pub-id>
          <pub-id pub-id-type="doi">10.1097/01.coc.0000135926.93116.c7</pub-id>
        </citation>
      </ref>
      <ref id="B36">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Senchenkov</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Moran</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Predictors of survival and recurrence in the surgical treatment of merkel cell carcinoma of the extremities</article-title>
          <source>J Surg Oncol</source>
          <year>2007</year>
          <volume>1;95</volume>
          <fpage>229</fpage>
          <lpage>234</lpage>
          <pub-id pub-id-type="pmid">17323336</pub-id>
          <pub-id pub-id-type="doi">10.1002/jso.20647</pub-id>
        </citation>
      </ref>
      <ref id="B37">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamana</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sueyama</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hamada</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cardiac metastasis from Merkel cell skin carcinoma</article-title>
          <source>Int J Clin Oncol</source>
          <year>2004</year>
          <volume>9</volume>
          <fpage>210</fpage>
          <lpage>212</lpage>
          <pub-id pub-id-type="pmid">15221609</pub-id>
          <pub-id pub-id-type="doi">10.1007/s10147-004-0396-2</pub-id>
        </citation>
      </ref>
      <ref id="B38">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mehrany</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Otley</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Weenig</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Roenigk</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>TH</given-names>
            </name>
          </person-group>
          <article-title>A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma</article-title>
          <source>Dermatol Surg</source>
          <year>2002</year>
          <volume>28</volume>
          <fpage>113</fpage>
          <lpage>117</lpage>
          <pub-id pub-id-type="pmid">11860419</pub-id>
          <pub-id pub-id-type="doi">10.1046/j.1524-4725.2002.02901.x</pub-id>
        </citation>
      </ref>
      <ref id="B39">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dancey</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Rayatt</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Soon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ilchshyn</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Merkel cell carcinoma: a report of 34 cases and literature review</article-title>
          <source>J Plast Reconstr Aesthet Surg</source>
          <year>2006</year>
          <volume>59</volume>
          <fpage>1294</fpage>
          <lpage>1299</lpage>
          <pub-id pub-id-type="pmid">17113506</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.bjps.2006.03.044</pub-id>
        </citation>
      </ref>
      <ref id="B40">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Allen</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Bowne</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Jaques</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Busam</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Coit</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
          <article-title>Merkel cell carcinoma: prognosis and treatment of patients from a single institution</article-title>
          <source>J Clin Oncol</source>
          <year>2005</year>
          <volume>23</volume>
          <fpage>2300</fpage>
          <lpage>2309</lpage>
          <pub-id pub-id-type="pmid">15800320</pub-id>
          <pub-id pub-id-type="doi">10.1200/JCO.2005.02.329</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
